Phase II evaluation of cis-diamminedichloroplatinum(II) in lung cancer.
D002945:Cisplatin / Q000627:therapeutic use* / Q000633:toxicity; D004341:Drug Evaluation; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*
D002945:Cisplatin